EWQ:NYE-iShares MSCI France ETF (USD)

ETF | Miscellaneous Region |

Last Closing

USD 39.78

Change

0.00 (0.00)%

Market Cap

N/A

Volume

0.39M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-22 )

Largest Industry Peers for Miscellaneous Region

Symbol Name Price(Change) Market Cap
FLGB Franklin FTSE United Kingdom E..

N/A

USD 0.72B
FLCA Franklin FTSE Canada ETF

N/A

USD 0.41B
EIDO iShares MSCI Indonesia ETF

N/A

USD 0.24B
EPOL iShares MSCI Poland ETF

N/A

USD 0.23B
GREK Global X MSCI Greece ETF

N/A

USD 0.16B
FLKR Franklin FTSE South Korea ETF

N/A

USD 0.13B
ISRA VanEck Israel ETF

N/A

USD 0.10B
EPHE iShares MSCI Philippines ETF

N/A

USD 0.09B
EPU iShares MSCI Peru ETF

N/A

USD 0.07B
FLMX Franklin FTSE Mexico ETF

N/A

USD 0.07B

ETFs Containing EWQ

DWCR Arrow DWA Tactical: Inter.. 0.00 % 0.79 %

N/A

USD 5.89M
BIKR 0.00 % 0.75 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Miscellaneous Region) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 10.87% 63% D 90% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.87% 63% D 90% A-
Trailing 12 Months  
Capital Gain -1.39% 32% F 29% F
Dividend Return 2.94% 73% C 46% F
Total Return 1.55% 32% F 27% F
Trailing 5 Years  
Capital Gain 29.37% 63% D 62% D
Dividend Return 16.71% 73% C 55% F
Total Return 46.08% 71% C- 62% D
Average Annual (5 Year Horizon)  
Capital Gain 9.91% 54% F 64% D
Dividend Return 11.94% 51% F 63% D
Total Return 2.03% 55% F 48% F
Risk Return Profile  
Volatility (Standard Deviation) 20.22% 68% D+ 54% F
Risk Adjusted Return 59.04% 73% C 72% C
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike